This document is a publication of a United States patent application, specifically US20260085063A1, filed on August 19, 2025. The application describes novel benzamide compounds and their use in inhibiting the SARS-CoV-2 papain-like protease (PLpro), aiming to promote antiviral effects and treat viral infections. The inventors listed are Jun Wang, Bin Tan, and Prakash Daulat Jadhav.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future intellectual property rights and may influence research and development in the pharmaceutical sector. Companies operating in this space should monitor the progress of this patent application and related filings for potential licensing opportunities or competitive landscape shifts.